M. Berman, Ph.D.
Associate Research Psychologist, Departments of Psychiatry and Biobehavioral
Sciences, and Medicine, at the David Geffen School of Medicine, UCLA;
UCLA Center for Neurovisceral Sciences and Women's Health (CNS/WH),
UCLA Division of Digestive Diseases
Neurovisceral Sciences & Women's Health
11301 Wilshire Boulevard
Building 115, Room 223
Los Angeles, CA 90073
On-campus mail: 38-154 NPI 175919 or BVA Bldg. 115, Room 223 179247
Tel: (310) 206-6657
Fax: (310) 794-2864
has been at UCLA for the past 12 years. He has made contributions
to the psychophysiology of substance abuse vulnerability, developmental
cognitive electrophysiology, and brain imaging of functional gastrointestinal
disorders. He is currently co-Principal Investigator of an National
Institute on Alcohol Abuse and Alcoholism study of electrophysiological,
neuropsychological, personality and genetic risk factors in children
of alcoholics. Dr. Berman is head of neuroimaging for the UCLA Center
for Neurovisceral Sciences and Women's Health.
Noble E. D2 dopamine receptor (DRD2) gene and family stress: interactive
effects on cognitive function in children. Behavior Genetics. 1997;
Munakata J, Naliboff B, Chang L, Mandelkern M, Silverman D, Kovalik
E, Mayer E. Gender differences in regional brain responses to visceral
pressure in IBS patients. European Journal of Pain. 2000; 4:157-172.
Chang L, Suyenobu B, Derbyshire S, Stains J, FitzGerald L, Mandelkern
M, Hamm L, Naliboff B, Mayer EA. Condition-specific deactivation
of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology.
2002. In press.